We are pleased to announce the acceptance for presentation of another Regenexx Research Paper at the Orthopedic Research Society this coming January. The paper is entitled: Safety and Complications Reporting Update on the Re-Implantation of Culture-Expanded Mesenchymal Stem Cells Using Autologous Platelet Lysate Technique. This is a 4 year study of 339 patients showing that the complications from stem cell injections (Regenexx-C) were far lower than those experienced by patients undergoing traditional orthopedic surgeries such as knee replacement. Knee outcome data will also be presented. This follows our presentation at ORS on orthopedic stem cells last year. We’re proud that the Centeno-Schultz clinic has again been chosen by the prestigious research organization to present our clinic’s data on this promising technique!
*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.
Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.
About the Author
Christopher J. Centeno, M.D. is an international expert and specialist in regenerative medicine and the clinical use of mesenchymal stem cells in orthopedics. He is board certified in physical medicine as well as rehabilitation and in pain management through The American Board of Physical Medicine and Rehabilitation.…